Amarin Corp Plc (AMRN)

[Whalatane]

Ralphey. U have 2 binary events approaching
MITIGATE and RESPECT EPA data

If both fail to show any significant clinical risk reduction AMRN will tank

So my question for U as an MD

Does high dose EPA reduce CV risks in a clinically significant manner ( more then 15 % RR ) or not ?

Off course if both trials show clinically significant risk reduction… anyone short AMRN will get trashed

Your opinion as an MD on high dose EPA for CV risk reduction?

Thx
Kiwi